Free Trial
NASDAQ:CGEN

Compugen (CGEN) Stock Price, News & Analysis

Compugen logo
$1.67 -0.03 (-1.76%)
Closing price 04:00 PM Eastern
Extended Trading
$1.70 +0.04 (+2.10%)
As of 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Compugen Stock (NASDAQ:CGEN)

Key Stats

Today's Range
$1.66
$1.73
50-Day Range
$1.25
$1.83
52-Week Range
$1.13
$2.66
Volume
113,511 shs
Average Volume
365,445 shs
Market Capitalization
$149.03 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.00
Consensus Rating
Buy

Company Overview

Compugen Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
30th Percentile Overall Score

CGEN MarketRank™: 

Compugen scored higher than 30% of companies evaluated by MarketBeat, and ranked 762nd out of 921 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Compugen has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Compugen has received no research coverage in the past 90 days.

  • Read more about Compugen's stock forecast and price target.
  • Earnings Growth

    Earnings for Compugen are expected to decrease in the coming year, from ($0.03) to ($0.12) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Compugen is -10.44, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Compugen is -10.44, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Compugen has a P/B Ratio of 2.69. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Compugen's valuation and earnings.
  • Percentage of Shares Shorted

    1.81% of the float of Compugen has been sold short.
  • Short Interest Ratio / Days to Cover

    Compugen has a short interest ratio ("days to cover") of 6.1.
  • Change versus previous month

    Short interest in Compugen has recently decreased by 0.68%, indicating that investor sentiment is improving.
  • Dividend Yield

    Compugen does not currently pay a dividend.

  • Dividend Growth

    Compugen does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.81% of the float of Compugen has been sold short.
  • Short Interest Ratio / Days to Cover

    Compugen has a short interest ratio ("days to cover") of 6.1.
  • Change versus previous month

    Short interest in Compugen has recently decreased by 0.68%, indicating that investor sentiment is improving.
  • Search Interest

    4 people have searched for CGEN on MarketBeat in the last 30 days. This is an increase of 33% compared to the previous 30 days.
  • MarketBeat Follows

    1 people have added Compugen to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Compugen insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 9.50% of the stock of Compugen is held by insiders.

  • Percentage Held by Institutions

    Only 12.22% of the stock of Compugen is held by institutions.

  • Read more about Compugen's insider trading history.
Receive CGEN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Compugen and its competitors with MarketBeat's FREE daily newsletter.

CGEN Stock News Headlines

INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Compugen First Quarter 2025 Earnings: Misses Expectations
See More Headlines

CGEN Stock Analysis - Frequently Asked Questions

Compugen's stock was trading at $1.53 at the beginning of 2025. Since then, CGEN shares have increased by 9.2% and is now trading at $1.67.

Compugen Ltd. (NASDAQ:CGEN) announced its earnings results on Monday, May, 19th. The biotechnology company reported ($0.08) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.06) by $0.02. The biotechnology company earned $2.28 million during the quarter, compared to analysts' expectations of $3.70 million. Compugen had a negative trailing twelve-month return on equity of 24.51% and a negative net margin of 51.27%.
Read the conference call transcript
.

Shares of CGEN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Compugen investors own include Oramed Pharmaceuticals (ORMP), TransEnterix (TRXDW), NVIDIA (NVDA), Meta Platforms (META), Tesla (TSLA), PayPal (PYPL) and

Company Calendar

Last Earnings
5/19/2025
Today
7/09/2025
Next Earnings (Estimated)
8/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:CGEN
CIK
1119774
Employees
70
Year Founded
1993

Price Target and Rating

High Price Target
$4.00
Low Price Target
$4.00
Potential Upside/Downside
+139.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$14.23 million
Pretax Margin
-34.78%

Debt

Sales & Book Value

Annual Sales
$27.86 million
Price / Cash Flow
N/A
Book Value
$0.62 per share
Price / Book
2.69

Miscellaneous

Free Float
80,759,000
Market Cap
$149.03 million
Optionable
Optionable
Beta
2.57

Social Links

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:CGEN) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners